MedPath

The Low Anterior resection syndrome study in Kashmir valley.

Not Applicable
Conditions
Health Condition 1: C20- Malignant neoplasm of rectum
Registration Number
CTRI/2022/05/042369
Lead Sponsor
Sher I Kashmir Institute of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

all patients who have been diagnosed with rectal cancer and will undergo curative sphincter preserving low anterior resection with partial or total mesorectal excision on or after 1st January 2020; comprehension of Urdu

Exclusion Criteria

The exclusion criteria will be as follows; presence of a permanent stoma; presence of metastatic disease; cognitive impairment and language issues; history of inflammatory bowel disease or any disease with bowel impairment issues like inflammatory bowel syndrome.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Validation of Urdu version of LARS scoreTimepoint: Self administered questionnaire will be filled in by the patient atleast 12 weeks after surgery/ ileostomy closure. Validation (primary outcome) will be done via statistical analysis after last patient is recruited.
Secondary Outcome Measures
NameTimeMethod
To determine Clinical Variables associated with LARSTimepoint: 2 years
© Copyright 2025. All Rights Reserved by MedPath